ASPIRO phase 1/2 gene therapy trial in X-linked motubular myopathy (XLMTM): update on preliminary safety and efficacy findings

被引：1
|
作者：
Dowling, J. [1 ]
Shieh, P. [2 ]
Kuntz, N. [3 ]
Bonnemann, C. [4 ]
Muller-Felber, W. [5 ]
Lawlor, M. [6 ]
Servais, L. [7 ]
Smith, B. [8 ]
Noursalehi, M. [9 ]
Rico, S. [9 ]
Prasad, S. [9 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] Childrens Hosp Chicago, Chicago, IL USA
[4] NIH, Bldg 10, Bethesda, MD 20892 USA
[5] Univ Munich, Munich, Germany
[6] Med Coll Wisconsin, Milwaukee, WI 53226 USA
[7] Hop Armand Trousseau, Paris, France
[8] Univ Florida, Gainesville, FL USA
[9] Audentes Therapeut, San Francisco, CA USA
来源：
NEUROMUSCULAR DISORDERS | 2019年 / 29卷
关键词：
D O I：
10.1016/j.nmd.2019.06.593
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
O.39
引用
收藏
页码：S207 / S207
页数：1
相关论文
共 50 条
  • [31] Immune function in X-linked retinoschisis subjects in an AAV8-RS1 phase I/IIa gene therapy trial
    Mishra, Alaknanda
    Vijayasarathy, Camasamudram
    Cukras, Catherine A.
    Wiley, Henry E.
    Sen, H. Nida
    Zeng, Yong
    Wei, Lisa L.
    Sieving, Paul A.
    MOLECULAR THERAPY, 2021, 29 (06) : 2030 - 2040
  • [32] Interim safety and efficacy of gene therapy for RLBP1-associated retinal dystrophy: a phase 1/2 trial
    Kvanta, Anders
    Rangaswamy, Nalini
    Holopigian, Karen
    Watters, Christine
    Jennings, Nicki
    Liew, Melissa S. H.
    Bigelow, Chad
    Grosskreutz, Cynthia
    Burstedt, Marie
    Venkataraman, Abinaya
    Westman, Sofie
    Geirsdottir, Asbjorg
    Stasi, Kalliopi
    Andre, Helder
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [33] The intragenic microRNA miR199A1 in the dynamin 2 gene contributes to the pathology of X-linked centronuclear myopathy
    Chen, Xin
    Gao, Yun-Qian
    Zheng, Yan-Yan
    Wang, Wei
    Wang, Pei
    Liang, Juan
    Zhao, Wei
    Tao, Tao
    Sun, Jie
    Wei, Lisha
    Li, Yeqiong
    Zhou, Yuwei
    Gan, Zhenji
    Zhang, Xuena
    Chen, Hua-Qun
    Zhu, Min-Sheng
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (26) : 8656 - 8667
  • [34] First-in-man Phase 1 Clinical Trial of Gene Therapy for Advanced Pancreatic Cancer: Safety, Biodistribution, and Preliminary Clinical Findings
    Buscail, Louis
    Bournet, Barbara
    Vernejoul, Fabienne
    Cambois, Gilles
    Lulka, Hubert
    Hanoun, Naima
    Dufresne, Marlene
    Meulle, Aline
    Vignolle-Vidoni, Alix
    Ligat, Laetitia
    Saint-Laurent, Nathalie
    Pont, Frederic
    Dejean, Sebastien
    Gayral, Marion
    Martins, Frederic
    Torrisani, Jerome
    Barbey, Odile
    Gross, Fabian
    Guimbaud, Rosine
    Otal, Philippe
    Lopez, Frederic
    Tiraby, Gerard
    Cordelier, Pierre
    MOLECULAR THERAPY, 2015, 23 (04) : 779 - 789
  • [35] INCEPTUS pre-phase 1, prospective, non-interventional, natural history run-in study to evaluate subjects aged 4 years and younger with X-linked myotubular myopathy (XLMTM)
    Servais, L.
    Shieh, P.
    Dowling, J.
    Kuntz, N.
    Mueller-Felber, W.
    Smith, B.
    Bonnemann, C.
    Muntoni, F.
    Bilder, D.
    Duong, T.
    Graham, R.
    Jain, M.
    Lawlor, M.
    MacBean, V.
    Noursalehi, M.
    Pitts, T.
    Rafferty, G.
    Rico, S.
    Prasad, S.
    NEUROMUSCULAR DISORDERS, 2019, 29 : S79 - S79
  • [36] EFFICACY AND SAFETY OF KRN23 IN ADULTS WITH X-LINKED HYPOPHOSPHATEMIA (XLH): DATA FROM A PHASE 2 EXTENSION STUDY
    Carpenter, T.
    Peacock, M.
    Weber, T.
    Portale, A.
    Insogna, K.
    Imel, E.
    Luca, D.
    Theodore-Oklota, C.
    Mealiffe, M.
    San Martin, J.
    Ruppe, M.
    OSTEOPOROSIS INTERNATIONAL, 2017, 28 : S336 - S336
  • [37] Gene Therapy- Mediated Reversal of Congenital Blindness: Demonstration of Efficacy in a Phase 1 Safety Trial
    Bennett, Jean
    Maguire, Albert M.
    Wright, J. Fraser
    Marshall, Kathleen A.
    Bennicelli, Jeannette
    Leroy, Bart P.
    Auricchio, Alberto
    Simonelli, Francesca
    McDonnell, Jennifer Wellman
    High, Katherine A.
    MOLECULAR THERAPY, 2009, 17 : S167 - S167
  • [38] Non-Clinical Efficacy and Safety Studies on G1XCGD, a Lentiviral Vector for Ex Vivo Gene Therapy of X-Linked Chronic Granulomatous Disease
    Brendel, Christian
    Rothe, Michael
    Santilli, Giorgia
    Charrier, Sabine
    Stein, Stefan
    Kunkel, Hana
    Abriss, Daniela
    Mueller-Kuller, Uta
    Gaspar, Bobby
    Modlich, Ute
    Galy, Anne
    Schannbach, Axel
    Thrasher, Adrian J.
    Grez, Manuel
    HUMAN GENE THERAPY CLINICAL DEVELOPMENT, 2018, 29 (02) : 69 - 79
  • [39] Protocol for the Phase 2 EDELIFE Trial Investigating the Efficacy and Safety of Intra-Amniotic ER004 Administration to Male Subjects with X-Linked Hypohidrotic Ectodermal Dysplasia
    Schneider, Holm
    Hadj-Rabia, Smail
    Faschingbauer, Florian
    Bodemer, Christine
    Grange, Dorothy K.
    Norton, Mary E.
    Cavalli, Riccardo
    Tadini, Gianluca
    Stepan, Holger
    Clarke, Angus
    Guillen-Navarro, Encarna
    Maier-Wohlfart, Sigrun
    Bouroubi, Athmane
    Porte, Florence
    GENES, 2023, 14 (01)
  • [40] Immune Reconstitution and Preliminary Safety Analysis Of 9 Patients Treated With Somatic Gene Therapy For X-Linked Severe Combined Immunodeficiency (SCID-X1) With a Self-Inactivating Gammaretroviral Vector
    Hacein-Bey-Abina, Salima
    Pai, Sung-Yun
    Bushman, Frederic
    Armant, Myriam
    Blanche, Stephane
    Blondeau, Johanna
    Caccavelli, Laure
    Daley, Heather
    Dansereau, Colleen
    deOliveira, Satiro
    Guo, Dongjing
    Hopkins, Gregory
    Lim, Annick
    London, Wendy B.
    Malani, Nirav
    Male, Frances
    Malik, Punam
    Marinovic, Maria Angelica
    McDonough, Sean
    Oleastro, Matias
    Picard, Capucine
    Ritz, Jerome
    Schambach, Axel
    Silberstein, Leslie E.
    Tsytsykova, Alla
    Van der Loo, Johannes C. M.
    Baum, Christopher
    Gaspar, H. Bobby
    Kohn, Donald B.
    Filipovich, Alexandra H.
    Notarangelo, Luigi Daniele
    Fischer, Alain
    Cavazzana-Calvo, Marina
    Williams, David A.
    Thrasher, Adrian J.
    BLOOD, 2013, 122 (21)
12345